Your basket is currently empty!
Opdivo + Yervoy fails adjuvant phase 3 trial
Bristol-Myers Squibb has revealed that its checkpoint inhibitor combination of Opdivo and Yervoy failed a phase 3 ...
News Archive
Kidney Cancer News
New Approach to Treating VHL RCC
The research could be used to develop more targeted kidney cancer drugs.
Researchers from Sweden’s Karolinska ...
Savolitinib not significantly efficacious in aRCC
Savolitinib, alone or in combination with durvalumab, did not demonstrate significant efficacy in patients with ...
Cabo + nivo & ipi delays kidney cancer progression
Adding cabozantinib (Cabometyx) to nivolumab (Opdivo) and ipilimumab (Yervoy) improved progression-free survival ...
Statins improve effectiveness of nivo for advanced kidney cancer
Statins are widely used in an ageing population, including subjects with solid malignancies. However, no ...
Kidney Cancer Diet & Nutrition
A guide for patients and their families.
This guide about a balanced diet and kidney cancer is intended to be a ...
EU kidney cancer clinical guidelines updated
Updated clinical guidelines published by the European Association of Urologists.
Government Cancer Services Report
The Health and Social Care Committee has published today the report of the panel of cancer experts they commissioned to assess and report on cancer services.
10-Year Cancer Plan: One Cancer Voice Consensus Statement
Today, along with 53 cancer charities, we speak with #OneCancerVoice and publish 10 tests that Sajid Javid's new 10-year Cancer Plan must meet if it is to be successful....
Live biotherapeutic development in kidney cancer
Live biotherapeutic product may enhance efficacy of immunotherapy for patients with metastatic kidney ...
CheckMate data support 1st nivo–cabo in advanced RCC
CheckMate 9ER HRQoL data support first-line nivolumab–cabozantinib in advanced RCC
People receiving nivolumab ...
EMA recommends pembrolizumab for the adjuvant treatment of RCC
Urologytimes.com reports that the European Medicines Agency’s Committee for Medicinal Products for Human Use ...
No results found.